Loading clinical trials...
Loading clinical trials...
Transperineal, MRI-guided, Prostate Biopsy: First Step to Focal Treatment of Prostate Cancer
Primary purpose: Complications and rehospitalizations after transperineal prostate biopsy MRI-guided are reduced than transrectal prostate biopsies. Secondary purposes: * Patients tolerance after transperineal prostate biopsy MRI-guided is better than after transrectal prostate biopsies. * Core of transperineal prostate biopsies are better than core of transrectal prostate biopsies * Study of correlation between radiologic images and anatomopathologic result * Description of needle track during the procedure * Description of real time template saturation prostate biopsy * Comparison of transperineal prostate biopsy relevance according to EBM * Comparison of 1.5T MRI and 3T MRI for prostate cancer detection
Age
40 - 80 years
Sex
MALE
Healthy Volunteers
No
Service d'urologie
Strasbourg, France
Start Date
May 1, 2015
Primary Completion Date
August 1, 2023
Completion Date
February 1, 2024
Last Updated
December 19, 2025
90
ACTUAL participants
Transperineal, MRI-guided, prostate biopsy
PROCEDURE
Transrectal prostate biopsy (TRB):
PROCEDURE
Lead Sponsor
University Hospital, Strasbourg, France
NCT05691465
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions